4AB.DE • XETRA
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
You don't hold 4AB.DE in your mock portfolio yet.
The very high PE ratio of 98.8 versus EPS of 2.00 suggests the stock is pricing in aggressive future earnings growth that is not yet visible in current profitability. On a pure valuation basis, this looks stretched relative to typical large-cap pharma multiples, implying elevated expectations and downside risk if growth underdelivers.
The stock is trading at €197.60, about 8.9% above its 200-day moving average of €181.46, and is up 5.4% over the last month, signaling a solid uptrend. An RSI of 65.89 shows strong momentum but not yet extreme overbought conditions, suggesting the trend is positive but getting extended.
Web traffic of about 851,905 monthly visitors and a flat job opening count of 1,000 suggest a stable but not rapidly accelerating operational footprint. Social media followings are large for LinkedIn and growing modestly on consumer platforms like Instagram and TikTok, pointing to steady brand engagement rather than a sharp inflection.
Technicals for AbbVie Inc. appear bullish in the near term, with the stock trading above its 200-day moving average and showing strong momentum. However, the very elevated PE relative to current EPS and only modest alternative data strength temper the outlook, leading to an overall neutral stance that balances upside momentum with valuation risk.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: